<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="molecules-25-02687-t002" orientation="portrait" position="float">
 <object-id pub-id-type="pii">molecules-25-02687-t002_Table 2</object-id>
 <label>Table 2</label>
 <caption>
  <p>In vitro cytotoxicity of 
   <italic>Cyperus articulatus</italic> rhizome essential oil (EO).
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Cell Lines</th>
    <th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Histological Type</th>
    <th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">IC
     <sub>50</sub> (95% CI) in µg/mL
    </th>
   </tr>
   <tr>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EO</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DOX</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5-FU</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">
     <bold>Cancer cells</bold>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
    <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
    <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
    <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">HepG2</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Human hepatocellular carcinoma</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">28.5
     <break/>(23.8–36.4)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.03
     <break/>(0.01–0.2)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.2
     <break/>(0.1–0.4)
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">HCT116</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Human colon carcinoma</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;50</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.1
     <break/>(0.1–0.2)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.5
     <break/>(0.3–1.1)
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">MCF-7</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Human breast adenocarcinoma</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">36.7
     <break/>(26.7–50.5)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.3
     <break/>(0.2–0.4)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">1.8
     <break/>(0.7–2.3)
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">HL-60</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Human promyelocytic leukemia</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">33.51
     <break/>(27.3–41.2)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.04
     <break/>(0.02–0.08)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">1.6
     <break/>(1.2–2.2)
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">B16-F10</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Mouse melanoma</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">39.7
     <break/>(32.1–49.0)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.2
     <break/>(0.2–0.2)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.5
     <break/>(0.3–0.8)
    </td>
   </tr>
   <tr>
    <td colspan="2" align="left" valign="middle" rowspan="1">
     <bold>Non-cancerous cell</bold>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
    <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
    <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MRC-5</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human lung fibroblast</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.0
     <break/>(39.6–53.6)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2
     <break/>(0.1–0.5)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.5
     <break/>(5.2–11.0)
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>The data are presented as IC
    <sub>50</sub> values, in μg/mL, with their respective 95% confidence interval (95% CI) obtained by nonlinear regression from three independent experiments carried out in duplicate, as measured by the Alamar blue assay after 72 h of incubation. Doxorubicin (DOX) and 5-fluorouracil (5-FU) were used as positive controls.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
